Autres langues AstraZeneca PLC NYSE

Actions

AZN

US0463531089

Produits pharmaceutiques

Marché Fermé - NYSE 22:00:02 06/10/2026			Varia. 5j.	Varia. 1 janv.
158,61 ^USD	+1,33 %		-3,41 %	+72,53 %

06/10	Les actions londoniennes progressent grâce au recul du pétrole et à la détente des rendements des emprunts d’État ; les valeurs de défense reculent	RE
06/10	Hausse à la Bourse de Stockholm, SEB pénalisée par le départ de son PDG, l’indice OMXS30 en hausse de 0,8 %	FW

Autres langues

06/10	London stocks gain on softer oil, easing gilt yields; Defence shares fall
06/10	Global markets live: Google, Nvidia, AstraZeneca, SpaceX, Paramount Skydance…
06/10	Afternoon Meeting: La renta variable pone a prueba al mercado de renta fija
06/10	Aktien stellen den Anleihemarkt auf die Probe
06/10	Stocks Are Testing the Bond Market
06/10	UK shares rise as softer oil, easing gilt yields lift sentiment
06/10	AstraZeneca : Alexion to showcase Phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting
06/10	Los índices bursátiles europeos suben impulsados por el sector sanitario -- Market Talk
06/10	Morning Meeting: Las bolsas siguen subiendo, como el coste de la vida
06/10	AstraZeneca Invests Over $1bn in Massachusetts
06/10	Morning Meeting: Aktien steigen weiter, genau wie die Lebenshaltungskosten
06/10	Stocks, Like the Cost of Living, Keep Going Up
06/10	BofA Forecasts 'In-line' Q3, Unchanged FY26 Outlook for AstraZeneca Amid Oncology Momentum
06/10	UK Stocks-Factors to watch on October 6
06/10	AstraZeneca Launches Research, Development Center in US
05/10	AztraZeneca opens new global strategic R&D centre in Massachusetts
05/10	AstraZeneca to Invest Over $1 Billion in Massachusetts
05/10	AstraZeneca to Invest Over $1 Billion in Massachusetts
05/10	AstraZeneca to invest over $1 billion in Massachusetts, boost workforce
05/10	AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment
05/10	AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts
05/10	Astrazeneca Announces the Opening of Its Newest Global Strategic Research and Development (R&D) Center, in Kendall Square, Cambridge, Massachusetts
05/10	Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
05/10	AstraZeneca completes USD2 billion Summit investment
05/10	Summit Therapeutics Secures $2 Billion Investment From AstraZeneca